HIGHLIGHTS
- Daiichi Sankyo working to develop an mRNA vaccine candidate to prevent COVID-19 infection in Japan.
- Daiichi Sankyo is helping researchers at University of Tokyo in R&D operations regarding vaccine against coronavirus.
Japanese pharmaceutical company Daiichi Sankyo working to develop a Messenger Ribonucleic Acid or Messenger RNA (mRNA) vaccine candidate to protect ag....
Tags : Daiichi Sankyo, Japan, Pharmaceuticals, coronavirus, COVID-19,
comments (0)